For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an ...

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

INNOVENT BIO (01801.HK)'s total product revenue for 2024 amounted to more than RMB8.2 billion, representing a robust YoY ...

That's important for AZ, as Tagrisso is starting to face the threat of competition from other EGFR drugs, including Johnson & Johnson's fast-growing EGFRxMET bispecific antibody Rybrevant ...

The European Commission (EC) has approved sugemalimab in combination with platinum-based chemotherapy for the first-line treatment of patients with metastatic NSCLC with no sensitizing EGFR mutations, ...

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

Panel asks govt to ensure consistent supply of drugs, scaling up testing facilities against TB: Gireesh Babu, New Delhi Monday, February 10, 2025, 08:00 Hrs [IST] A Parliamentary ...

Explore how genetic testing and precision oncology are revolutionizing cancer treatment by offering personalized care and ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

On World Cancer Day, we come together to reflect on the progress made in the fight against cancer and the importance of ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.